# Aclaris Therapeutics, Inc.: Form DEF 14A, filed Apr 25, 2024

- Company: [Aclaris Therapeutics, Inc.](/companies/acrs.md) (CIK 1557746)
- Form: DEF 14A
- Filed: 2024-04-25
- Accepted by EDGAR: Apr 25, 2024, 07:00 ET
- Period: 2024-06-06
- Accession: 0001558370-24-005677
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1557746/000155837024005677/acrs-20240606xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1557746/000155837024005677/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1557746/000155837024005677/acrs-20240606xdef14a.htm

Filed Apr 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-005677. Last ingested by Listed: Oct 27, 2026, 17:27 ET. No prices; not investment advice.